恶性胸壁瘤的跨学科治疗
Koblandy Khamitov1,2, Wojciech Dudek1,2, Andreas Arkudas1,3
1Faculty of Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, 91054 Erlangen, Germany.
Journal of personalized medicine
|September 28, 2023
概括
对恶性胸壁瘤 (MCWTs) 的手术切除是可行的,对精心挑选的患者提供良好的结果. 初级MCWT的生存率高于二级MCWT的生存率.
科学领域:
- 胸部外科手术 胸部外科手术
- 手术瘤学手术瘤学
- 重建性手术是一种重建性手术.
背景情况:
- 恶性胸壁瘤 (MCWTs) 带来了重大挑战,特别是那些需要全厚胸壁切除和重建的瘤.
- 手术管理需要一个多学科的方法,涉及胸部和塑料重建外科医生.
研究的目的:
- 审查对初级和转移性MCWT进行胸壁切除的机构经验.
- 为了评估这些切除后的术后结果和术后整体存活率 (OS).
主要方法:
- 在2000年至2019年期间,对患者进行了为初级和二级MCWTs进行手术切除的回顾性分析.
- 包括关于治疗与息的意图,重建要求和术后并发症的数据.
主要成果:
- 在42名患者中,33名 (78%) 患有二次MCWT;40名 (95%) 需要胸壁重建.
- 术后并发症发生在13名 (31%) 患者中,其中1名术后死亡 (2.3%).
- 五年运行周期为51.9%,对于二级 (42.6%) 和初级 (87.5%) 的MCWT显著较低.
结论:
- 对于MCWTs的胸壁切除在选定的患者中是可行的,产生良好的术后结果.
- 对于二次MCWT的手术可以有效地以息的意图进行.
- 结果强调了患者选择的重要性以及初级和二级MCWT之间的生存差异.
相关概念视频
01:26Flail Chest-II
197
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
197
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:27Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K